ASRT vs HAL · rev $125.0M vs P/E 9.3, $19.05B cap
Assertio Therapeutics Inc (ASRT) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
HAL does not have a complete income-statement cache yet.
ASRT currently screens at market cap $151.5M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the ASRT and HAL stock pages for the full models.
Not investment advice.